Your browser doesn't support javascript.
loading
Electroconvulsive therapy for catatonia secondary to neuroleptic malignant syndrome in a patient with multiple sclerosis.
Harley, J A; Peebles, C; Porter, R J.
Affiliation
  • Harley JA; 1 Community Alcohol and Drug Service and Christchurch Opioid Recovery Service, Canterbury District Health Board, Hillmorton Hospital, Christchurch, New Zealand.
  • Peebles C; 2 Psychiatric Consultation Service and Older Persons Mental Health Service, Canterbury District Health Board, Christchurch, New Zealand.
  • Porter RJ; 3 Department of Psychological Medicine, University of Otago, Christchurch and Psychiatric Services for Adults with an Intellectual Disability (PSAID), Canterbury District Health Board, Christchurch, New Zealand.
Aust N Z J Psychiatry ; 53(7): 703-704, 2019 07.
Article in En | MEDLINE | ID: mdl-31072113
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Catatonia / Electroconvulsive Therapy / Haloperidol / Multiple Sclerosis / Neuroleptic Malignant Syndrome Type of study: Etiology_studies Limits: Adult / Female / Humans Language: En Journal: Aust N Z J Psychiatry Year: 2019 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Catatonia / Electroconvulsive Therapy / Haloperidol / Multiple Sclerosis / Neuroleptic Malignant Syndrome Type of study: Etiology_studies Limits: Adult / Female / Humans Language: En Journal: Aust N Z J Psychiatry Year: 2019 Document type: Article Affiliation country: